Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Aug;74(8):1016–1022. doi: 10.1136/jnnp.74.8.1016

Neurovirological methods and their applications

P Kennedy 1
PMCID: PMC1738595  PMID: 12876227

Full Text

The Full Text of this article is available as a PDF (114.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitman T. J. DNA microarrays in medical practice. BMJ. 2001 Sep 15;323(7313):611–615. doi: 10.1136/bmj.323.7313.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blumberg B. M., Gelbard H. A., Epstein L. G. HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res. 1994 May;32(2):253–267. doi: 10.1016/0168-1702(94)90044-2. [DOI] [PubMed] [Google Scholar]
  3. Brahic Michel. Theiler's virus infection of the mouse, or: of the importance of studying animal models. Virology. 2002 Sep 15;301(1):1–5. doi: 10.1006/viro.2002.1607. [DOI] [PubMed] [Google Scholar]
  4. Brown S. M., Harland J., MacLean A. R., Podlech J., Clements J. B. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol. 1994 Sep;75(Pt 9):2367–2377. doi: 10.1099/0022-1317-75-9-2367. [DOI] [PubMed] [Google Scholar]
  5. Brown S. M., Subak-Sharpe J. H., Warren K. G., Wroblewska Z., Koprowski H. Detection by complementation of defective or uninducible (herpes simplex type 1) virus genomes latent in human ganglia. Proc Natl Acad Sci U S A. 1979 May;76(5):2364–2368. doi: 10.1073/pnas.76.5.2364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carr D. J., Campbell I. L. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. J Neurovirol. 1999 Oct;5(5):449–457. doi: 10.3109/13550289909045373. [DOI] [PubMed] [Google Scholar]
  7. Chen Benjamin P., Lane Thomas E. Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. J Neurovirol. 2002 Feb;8(1):58–63. doi: 10.1080/135502802317247820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chua K. B., Bellini W. J., Rota P. A., Harcourt B. H., Tamin A., Lam S. K., Ksiazek T. G., Rollin P. E., Zaki S. R., Shieh W. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000 May 26;288(5470):1432–1435. doi: 10.1126/science.288.5470.1432. [DOI] [PubMed] [Google Scholar]
  9. Cohrs R. J., Randall J., Smith J., Gilden D. H., Dabrowski C., van Der Keyl H., Tal-Singer R. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol. 2000 Dec;74(24):11464–11471. doi: 10.1128/jvi.74.24.11464-11471.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cosby S. L., McQuaid S., Taylor M. J., Bailey M., Rima B. K., Martin S. J., Allen I. V. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol. 1989 Aug;70(Pt 8):2027–2036. doi: 10.1099/0022-1317-70-8-2027. [DOI] [PubMed] [Google Scholar]
  11. Drescher Kristen M., Zoecklein Laurie J., Rodriguez Moses. ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination. J Neurovirol. 2002 Oct;8(5):452–458. doi: 10.1080/13550280260422767. [DOI] [PubMed] [Google Scholar]
  12. During M. J., Naegele J. R., O'Malley K. L., Geller A. I. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 1994 Nov 25;266(5189):1399–1403. doi: 10.1126/science.266.5189.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Evans D. M., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V., Jr Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985 Apr 11;314(6011):548–550. doi: 10.1038/314548a0. [DOI] [PubMed] [Google Scholar]
  14. Geller A. I., During M. J., Oh Y. J., Freese A., O'Malley K. An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells. J Neurochem. 1995 Feb;64(2):487–496. doi: 10.1046/j.1471-4159.1995.64020487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gendelman Howard E. Neural immunity: Friend or foe? J Neurovirol. 2002 Dec;8(6):474–479. doi: 10.1080/13550280290168631. [DOI] [PubMed] [Google Scholar]
  16. Glorioso J. C., Goins W. F., Meaney C. A., Fink D. J., DeLuca N. A. Gene transfer to brain using herpes simplex virus vectors. Ann Neurol. 1994;35 (Suppl):S28–S34. doi: 10.1002/ana.410350710. [DOI] [PubMed] [Google Scholar]
  17. Iizuka N., Kohara M., Hagino-Yamagishi K., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol. 1989 Dec;63(12):5354–5363. doi: 10.1128/jvi.63.12.5354-5363.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jacobson S. Association of human herpesvirus-6 and multiple sclerosis: here we go again? J Neurovirol. 1998 Oct;4(5):471–473. doi: 10.3109/13550289809113491. [DOI] [PubMed] [Google Scholar]
  19. Johnson R. T. Neurovirology: evolution of a new discipline. J Neurovirol. 1995 Mar;1(1):2–4. doi: 10.3109/13550289509111005. [DOI] [PubMed] [Google Scholar]
  20. Jones Jeremy O., Arvin Ann M. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J Virol. 2003 Jan;77(2):1268–1280. doi: 10.1128/JVI.77.2.1268-1280.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kellam P. Post-genomic virology: the impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions. Rev Med Virol. 2001 Sep-Oct;11(5):313–329. doi: 10.1002/rmv.328. [DOI] [PubMed] [Google Scholar]
  22. Kennedy P. G. E., Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):237–238. doi: 10.1136/jnnp.73.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kennedy P. G. A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985. Q J Med. 1988 Jul;68(255):533–540. [PubMed] [Google Scholar]
  24. Kennedy P. G., Clements G. B., Brown S. M. Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus. Brain. 1983 Mar;106(Pt 1):101–119. doi: 10.1093/brain/106.1.101. [DOI] [PubMed] [Google Scholar]
  25. Kennedy P. G., Gairns J., MacLean A. R. Replication of the herpes simplex virus type 1 RL1 mutant 1716 in primary neuronal cell cultures--possible relevance to use as a viral vector. J Neurol Sci. 2000 Oct 1;179(Suppl 1-2):108–114. doi: 10.1016/s0022-510x(00)00388-9. [DOI] [PubMed] [Google Scholar]
  26. Kennedy P. G., Grinfeld E., Bell J. E. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol. 2000 Dec;74(24):11893–11898. doi: 10.1128/jvi.74.24.11893-11898.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kennedy P. G., Grinfeld E., Bontems S., Sadzot-Delvaux C. Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology. 2001 Oct 25;289(2):218–223. doi: 10.1006/viro.2001.1173. [DOI] [PubMed] [Google Scholar]
  28. Kennedy P. G., Grinfeld E., Gow J. W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4658–4662. doi: 10.1073/pnas.95.8.4658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kennedy P. G. Molecular studies of viral pathogenesis in the central nervous system. The Linacre Lecture 1991. J R Coll Physicians Lond. 1992 Apr;26(2):204–214. [PMC free article] [PubMed] [Google Scholar]
  30. Kennedy P. G., Narayan O., Ghotbi Z., Hopkins J., Gendelman H. E., Clements J. E. Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J Exp Med. 1985 Dec 1;162(6):1970–1982. doi: 10.1084/jem.162.6.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kennedy P. G. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain. 1997 Jul;120(Pt 7):1245–1259. doi: 10.1093/brain/120.7.1245. [DOI] [PubMed] [Google Scholar]
  32. Kennedy P. G., Steiner I. On the possible viral aetiology of multiple sclerosis. QJM. 1994 Sep;87(9):523–528. doi: 10.1093/oxfordjournals.qjmed.a068963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kennedy P. G. The use of molecular techniques in studying viral pathogenesis in the nervous system. Trends Neurosci. 1990 Oct;13(10):424–431. doi: 10.1016/0166-2236(90)90125-t. [DOI] [PubMed] [Google Scholar]
  34. Kennedy P. G. The widening spectrum of infectious neurological disease. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):629–632. doi: 10.1136/jnnp.53.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kennedy Peter G. E. Varicella-zoster virus latency in human ganglia. Rev Med Virol. 2002 Sep-Oct;12(5):327–334. doi: 10.1002/rmv.362. [DOI] [PubMed] [Google Scholar]
  36. Kimberlin D. W., Whitley R. J. Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J Neurovirol. 1998 Oct;4(5):474–485. doi: 10.3109/13550289809113492. [DOI] [PubMed] [Google Scholar]
  37. Lungu O., Annunziato P. W., Gershon A., Staugaitis S. M., Josefson D., LaRussa P., Silverstein S. J. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10980–10984. doi: 10.1073/pnas.92.24.10980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nash D., Mostashari F., Fine A., Miller J., O'Leary D., Murray K., Huang A., Rosenberg A., Greenberg A., Sherman M. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001 Jun 14;344(24):1807–1814. doi: 10.1056/NEJM200106143442401. [DOI] [PubMed] [Google Scholar]
  39. Papanastassiou V., Rampling R., Fraser M., Petty R., Hadley D., Nicoll J., Harland J., Mabbs R., Brown M. The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Ther. 2002 Mar;9(6):398–406. doi: 10.1038/sj.gt.3301664. [DOI] [PubMed] [Google Scholar]
  40. Quinlivan Mark, Hawrami Khidir, Barrett-Muir Winsome, Aaby Peter, Arvin Ann, Chow Vincent T., John T. Jacob, Matondo Patrick, Peiris Malik, Poulsen Anja. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis. 2002 Sep 13;186(7):888–894. doi: 10.1086/344228. [DOI] [PubMed] [Google Scholar]
  41. Rampling R., Cruickshank G., Papanastassiou V., Nicoll J., Hadley D., Brennan D., Petty R., MacLean A., Harland J., McKie E. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 2000 May;7(10):859–866. doi: 10.1038/sj.gt.3301184. [DOI] [PubMed] [Google Scholar]
  42. Sharpe A. H., Fields B. N. Pathogenesis of viral infections. Basic concepts derived from the reovirus model. N Engl J Med. 1985 Feb 21;312(8):486–497. doi: 10.1056/NEJM198502213120806. [DOI] [PubMed] [Google Scholar]
  43. Steiner I., Kennedy P. G. Molecular biology of herpes simplex virus type 1 latency in the nervous system. Mol Neurobiol. 1993 Summer;7(2):137–159. doi: 10.1007/BF02935640. [DOI] [PubMed] [Google Scholar]
  44. Steiner I., Spivack J. G., Lirette R. P., Brown S. M., MacLean A. R., Subak-Sharpe J. H., Fraser N. W. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 1989 Feb;8(2):505–511. doi: 10.1002/j.1460-2075.1989.tb03404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tuffereau C., Leblois H., Bénéjean J., Coulon P., Lafay F., Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology. 1989 Sep;172(1):206–212. doi: 10.1016/0042-6822(89)90122-0. [DOI] [PubMed] [Google Scholar]
  46. Warren K. G., Koprowski H., Lonsdale D. M., Brown S. M., Subak-Sharpe J. H. The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia. J Gen Virol. 1979 Apr;43(1):151–171. doi: 10.1099/0022-1317-43-1-151. [DOI] [PubMed] [Google Scholar]
  47. Whitley R. J., Alford C. A., Hirsch M. S., Schooley R. T., Luby J. P., Aoki F. Y., Hanley D., Nahmias A. J., Soong S. J. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16;314(3):144–149. doi: 10.1056/NEJM198601163140303. [DOI] [PubMed] [Google Scholar]
  48. Whitley R., Lakeman A. D., Nahmias A., Roizman B. Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21;307(17):1060–1062. doi: 10.1056/NEJM198210213071706. [DOI] [PubMed] [Google Scholar]
  49. Wilcox C. L., Johnson E. M., Jr Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol. 1987 Jul;61(7):2311–2315. doi: 10.1128/jvi.61.7.2311-2315.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yan Xiuzhen, Mohankumar Puliyur S., Dietzschold Bernhard, Schnell Matthies J., Fu Zhen F. The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain. J Neurovirol. 2002 Aug;8(4):345–352. doi: 10.1080/13550280290100707. [DOI] [PubMed] [Google Scholar]
  51. ZURHEIN G., CHOU S. M. PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE. Science. 1965 Jun 11;148(3676):1477–1479. doi: 10.1126/science.148.3676.1477. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES